SuperHealthGuard

SuperHealthGuard appears to have been an online seller of health products, including traditional Chinese medicine products marketed into the United States from Hong Kong. Publicly available evidence primarily ties the name to a June 26, 2020 FDA and FTC warning letter concerning unapproved and misbranded COVID-19-related claims for products sold through superhealthguard.com. The entity does not appear to be a drug developer, biotech innovator, or clinical-stage pharmaceutical company with a disclosed R&D pipeline. Instead, the available record suggests it functioned as a commercial reseller or distributor of healthcare-related products. Very limited independent corporate information is publicly available beyond the regulatory enforcement record.